tirzepatide type 1 diabetes trial vs. Semaglutide: What You Should Know Lilly Shows Tirzepatide Superiority in

If additional glycemic control is needed after at least 4 weeks on the 0.5 mg dose, the dosage may be slowly increased to 2 mg once weekly (note the maximum dose for the treatment of obesity is 2.4mg)

For those with Medicaid or Medicare, semaglutide injections are covered for the management of type II diabetes but arent likely to be covered for weight loss or weight management

Some of that weight loss comes from lean muscle mass, particularly when protein intake is inadequate or resistance training is absent

This approach minimises the risk of gastrointestinal adverse effects, which are significantly more common when higher doses are resumed without proper titration

Containers shown for illustration purposes only

The biggest differences come down to formulation, cost, and accessibility